These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4873852)

  • 1. Spray-congealed fomulations of sulfaethylthiadiazole (SETD) and waxes for prolonged-release medication. Effect of wax.
    Cusimano AG; Becker CH
    J Pharm Sci; 1968 Jul; 57(7):1104-12. PubMed ID: 4873852
    [No Abstract]   [Full Text] [Related]  

  • 2. Release study of sulfaethylthiadiazole (SETD) from a tablet dosage form prepared from spray-congealed formulations of SETD and wax.
    Hamid IS; Becker CH
    J Pharm Sci; 1970 Apr; 59(4):511-4. PubMed ID: 4909462
    [No Abstract]   [Full Text] [Related]  

  • 3. Surfactant effects on spray-congealed formulations of sulfaethylthiadiazole--wax.
    John PM; Becker CH
    J Pharm Sci; 1968 Apr; 57(4):584-9. PubMed ID: 5652147
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfaethylthiadiazole (SETD) release from synthetic wax prolonged-release particles. I. Effect of dispersant concentration.
    Robinson IC; Becker CH
    J Pharm Sci; 1968 Jan; 57(1):49-53. PubMed ID: 5694995
    [No Abstract]   [Full Text] [Related]  

  • 5. Spray-congealed formulations of sulfaethidole (SETD) and waxes for prolonged-release medication. Effect of modifiers.
    Raghunathan Y; Becker CH
    J Pharm Sci; 1968 Oct; 57(10):1748-55. PubMed ID: 5684747
    [No Abstract]   [Full Text] [Related]  

  • 6. Some wax formulations of sulfaethylthiadiazole produced by aqueous dispersion for prolonged-release medication.
    Draper EB; Becker CH
    J Pharm Sci; 1966 Apr; 55(4):376-80. PubMed ID: 6012855
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of surface-active and emulsifying properties of oxyethylated alcohols of wool wax in the preparation of ointments and emulsions. I].
    Bashura GS; Gluzman MKh; Labuns'kiĭ EV; Trunova MA; Levitskaia IB
    Farm Zh; 1969; 24(3):53-7. PubMed ID: 5394301
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of a novel wax matrix system using aminoalkyl methacrylate copolymer E and ethylcellulose to suppress the bitter taste of acetaminophen.
    Shiino K; Iwao Y; Miyagishima A; Itai S
    Int J Pharm; 2010 Aug; 395(1-2):71-7. PubMed ID: 20472050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of environmental conditions on the release of brompheniramine from protein/wax matrix tablets.
    Groves MJ; Galindez FE
    Acta Pharm Suec; 1976; 13(4):373-84. PubMed ID: 11641
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel mathematical model considering change of diffusion coefficient for predicting dissolution behavior of acetaminophen from wax matrix dosage form.
    Nitanai Y; Agata Y; Iwao Y; Itai S
    Int J Pharm; 2012 May; 428(1-2):82-90. PubMed ID: 22405986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the surface-active, colloid-micellar and solubilizing properties of a series of hydroxyethylated alcohols of wool wax].
    Bashura GS; Liapunov NA; Solon'ko VN
    Farmatsiia; 1976; 25(1):24-8. PubMed ID: 946420
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods of studying aging and stabilization of spray-congealed solid dispersions with carnauba wax. 1. Microcalorimetric investigation.
    Emås M; Nyqvist H
    Int J Pharm; 2000 Mar; 197(1-2):117-27. PubMed ID: 10704799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release from inert wax matrixes II: effect of surfactants on tripelennamine hydrochloride release.
    Dakkuri A; Schroeder HG; DeLuca PP
    J Pharm Sci; 1978 Mar; 67(3):354-7. PubMed ID: 641722
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro release of ferrous sulphate, aspirin and phenobarbitone from some waxy matrices.
    Khalil SA; el-Gamal SS; Abdel Khalek MM
    Acta Pharm Suec; 1971 Jun; 8(3):311-8. PubMed ID: 4934658
    [No Abstract]   [Full Text] [Related]  

  • 16. Melt solidification technique: incorporation of higher wax content in ibuprofen beads.
    Kamble R; Maheshwari M; Paradkar A; Kadam S
    AAPS PharmSciTech; 2004 Oct; 5(4):e61. PubMed ID: 15760058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of a drug from a dosage form.
    Stelmach H; Robinson JR; Eriksen SP
    J Pharm Sci; 1965 Oct; 54(10):1453-8. PubMed ID: 5899123
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of wax coatings on release rate of anions from ion-exchange resin beads.
    Motycka S; Nairn JG
    J Pharm Sci; 1978 Apr; 67(4):500-3. PubMed ID: 641757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of some factors affecting the in-vitro release of drug from prolonged release granulations. 3. Effects of particle size, enzymatic contents of pepsin and pancreatin, bile and ionic concentration.
    Asker AF; Motawi AM; Abdel-Khalek MM
    Pharmazie; 1971 Apr; 26(4):215-7. PubMed ID: 4930110
    [No Abstract]   [Full Text] [Related]  

  • 20. Formulation of wax oxybenzone microparticles using a factorial approach.
    Gomaa YA; Darwish IA; Boraei NA; El-Khordagui LK
    J Microencapsul; 2010; 27(7):628-39. PubMed ID: 20681744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.